Vascular Closure Devices Global Market Report 2025
상품코드:1695237
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 200 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
혈관 폐쇄 기기 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 6.7%의 CAGR로 21억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 외래 수술 센터의 증가, 당일 퇴원으로의 전환, 환자 중심의 접근 방식, 의료비 절감 노력, 심혈관질환의 이환율 증가 등에 기인합니다. 예측 기간의 세계 트렌드에는 경피적 관상동맥 중재술의 채택, 의학 연구 분야의 세계 협력, 원격 환자 모니터링, 영상 기술과의 통합, 기기 설계의 혁신 등이 포함됩니다.
심혈관질환의 급증은 혈관 폐쇄 기기(VCDs) 시장의 성장을 크게 촉진할 것으로 예상됩니다. 심혈관질환(CVD)은 심장과 혈관에 영향을 미치고 심장의 정상적인 혈액 순환을 방해하는 다양한 질환을 포함하며, VCD는 기존의 기계적 압박을 대체하여 대퇴부 동맥 접근 지점을 신속하게 차단하여 지혈을 빠르게 할 수 있습니다. 이를 통해 지혈이 빠르게 이루어지고, 시술 후 출혈과 하혈의 위험을 줄일 수 있습니다. 일례로, 2023년 6월 출입국관리청(Immigration and Checkpoints Authority)의 데이터에 따르면, 싱가포르에서 심장병 및 고혈압성 질환으로 인한 사망자 수는 2021년 6,238명에서 2022년 6,884명으로 증가했습니다. 에스컬레이트되고 있습니다. 이에 따라 심혈관질환의 유병률 증가는 혈관 폐쇄 기기 시장 확대를 촉진하는 주요 요인이 될 것으로 예상됩니다.
비만 유병률의 증가는 혈관 폐쇄 기기 시장의 확대를 촉진할 것으로 예상됩니다. 비만은 섭취하는 칼로리와 소비하는 칼로리의 불균형으로 인해 체지방이 과도하게 축적되어 건강에 악영향을 미치는 질환입니다. 혈관 폐쇄 기기는 출혈성 합병증의 위험을 줄이고, 해부학적 요인으로 인한 문제나 의료 시술 중 과도한 지방 조직으로 인한 잠재적 합병증에 대처하기 위해 과체중 및 비만 환자에게 사용됩니다. 예를 들어, 2023년 3월 스위스에 본부를 둔 세계 심혈관 단체인 세계심장재단(World Heart Foundation)은 전 세계적으로 약 23억 명의 성인과 어린이가 비만 또는 과체중이라고 보고했습니다. 현재 추세대로라면 2025년까지 비만 인구는 27억 명에 달할 것으로 예측됩니다. 그 결과, 비만 유병률의 증가는 혈관 폐쇄 기기 시장의 성장을 주도하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 혈관 폐쇄 기기 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 혈관 폐쇄 기기 시장 : 성장률 분석
세계의 혈관 폐쇄 기기 시장 실적 : 규모와 성장, 2019-2024
세계의 혈관 폐쇄 기기 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 혈관 폐쇄 기기 전체 시장(TAM)
제6장 시장 세분화
세계의 혈관 폐쇄 기기 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
패시브 근사기
액티브 근사기
외부 지혈 기구
세계의 혈관 폐쇄 기기 시장 : 접근별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
대퇴부 접근
레이디얼 접근
세계의 혈관 폐쇄 기기 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
급성기 케어 시설
병원
클리닉
기타 최종사용자
세계의 혈관 폐쇄 기기 시장, 수동 근사기 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
봉합 기반 디바이스
피브린 실란트
세계의 혈관 폐쇄 기기 시장, 액티브 근사기 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
기계 장비
확장 디바이스
세계의 혈관 폐쇄 기기 시장 외부 지혈 기구 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
압박 붕대
조절 가능한 지혈 장비
제7장 지역별·국가별 분석
세계의 혈관 폐쇄 기기 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 혈관 폐쇄 기기 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
혈관 폐쇄 기기 시장 : 경쟁 구도
혈관 폐쇄 기기 시장 : 기업 개요
Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Terumo Corporation
C.R. Bard Inc.
Cook Medical Inc.
W. L. Gore & Associates Inc.
Maquet Getinge Group
Teleflex Inc.
BTG International Inc.
Biotronik GMBH & CO.KG
Merit Medical System Inc.
Vygon SA
Cardiovascular Systems Inc.
Sirtex Medical Limited
Endologix LLC
TZ Medical Inc.
Cardiva Medical Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
혈관 폐쇄 기기 시장 2029 : 새로운 기회를 제공하는 국가
혈관 폐쇄 기기 시장 2029 : 새로운 기회를 제공하는 부문
혈관 폐쇄 기기 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Vascular closure devices are medical devices designed to seal the entry point in an artery following a catheterization procedure, minimizing the risk of complications such as bleeding or hematoma formation. These devices accelerate the natural healing process at the access site.
The primary categories of vascular closure devices include passive approximators, active approximators, and external hemostatic devices. Passive approximators involve the use of plugs, sealants, or gels at the arteriotomy site without physically closing the arteriotomy. These devices are utilized for femoral and radial access procedures and find applications in acute care facilities, hospitals, clinics, and other healthcare settings.
The vascular closure devices market research report is one of a series of new reports from The Business Research Company that provides vascular closure devices market statistics, including vascular closure devices industry global market size, regional shares, competitors with a vascular closure devices market share, detailed vascular closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the vascular closure devices industry. This vascular closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vascular closure devices market size has grown strongly in recent years. It will grow from $1.53 billion in 2024 to $1.63 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in minimally invasive procedures, aging population demographics, patient preference for shorter recovery times, increased catheterization lab procedures, focus on outpatient care.
The vascular closure devices market size is expected to see strong growth in the next few years. It will grow to $2.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rise in ambulatory surgery centers, shift toward same-day discharge, patient-centric approaches, healthcare cost containment initiatives, increasing incidence of cardiovascular diseases. Major trends in the forecast period include adoption of percutaneous coronary intervention, global collaboration in medical research, remote patient monitoring, integration with imaging technologies, technological innovations in device design.
The expected surge in the prevalence of cardiovascular diseases is projected to significantly propel the growth of the vascular closure devices (VCDs) market. Cardiovascular diseases (CVDs) encompass a spectrum of conditions impacting the heart or blood vessels, disrupting normal blood circulation in the heart. VCDs serve as an alternative to traditional mechanical compression, swiftly sealing the femoral artery access point. This expedites the achievement of hemostasis and mitigates the risk of post-procedural bleeding or hemorrhaging. As an illustration, data from the Immigration and Checkpoints Authority in June 2023 indicated a rise in fatalities attributed to heart and hypertensive diseases in Singapore, escalating from 6,238 in 2021 to 6,884 in 2022. Consequently, the escalating prevalence of cardiovascular diseases is anticipated to be a major driver propelling the expansion of the vascular closure devices market.
The growing prevalence of obesity is expected to drive the expansion of the vascular closure devices market. Obesity is a medical condition characterized by an excessive accumulation of body fat that negatively affects health, resulting from an imbalance between calories consumed and calories expended. Vascular closure devices are used in overweight and obese patients to reduce the risk of bleeding complications and to address challenges arising from anatomical factors and potential complications due to excess adipose tissue during medical procedures. For example, in March 2023, the World Heart Foundation, a Switzerland-based global cardiovascular organization, reported that approximately 2.3 billion adults and children worldwide are obese or overweight. With the current trends, it is projected that the number of people living with obesity will reach 2.7 billion by 2025. As a result, the increasing prevalence of obesity is driving the growth of the vascular closure devices market.
Major companies in the vascular closure devices market are focusing on developing technologies like innovative collapsible disc technology to improve patient outcomes, reduce recovery times, and enhance the overall effectiveness and ease of vascular procedures. This innovative collapsible disc technology features a design that allows the disc to be easily collapsed and expanded for efficient storage and portability, increasing convenience and versatility in various applications such as sporting goods, outdoor gear, and packaging solutions. For example, in June 2024, Haemonetics Corporation, a US-based medical technology company, launched the VASCADE MVP XL. This mid-bore vascular closure device incorporates 58% more collagen and a larger disc compared to its predecessor, the VASCADE MVP system. The new design aims to provide a more robust closure solution, ensuring quicker recovery and better patient outcomes.
In October 2023, Cordis Corporation, a US-based global medical company, acquired M.A. Med Alliance SA for an undisclosed amount. This acquisition allows Cordis Corporation to expand its product portfolio and strengthen its position in the medical device market. M.A. Med Alliance SA, a Sweden-based medical technology company, specializes in creating innovative solutions for vascular interventions.
Major companies operating in the vascular closure devices market report are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Koninklijke Philips NV, Boston Scientific Corporation, Terumo Corporation, C.R. Bard Inc., Cook Medical Inc., W. L. Gore & Associates Inc., Maquet Getinge Group, Teleflex Inc., BTG International Inc., Biotronik GMBH & CO.KG, Merit Medical System Inc., Vygon SA, Cardiovascular Systems Inc., Sirtex Medical Limited, Endologix LLC, TZ Medical Inc., Cardiva Medical Inc., Essential Medical Inc., KOAG LLC, Morris Innovative Inc., Vasorum Ltd., Scion BioMedical Inc., Z-Media LLC, Advanced Vascular Dynamics, Transluminal Technologies Inc., Tricol Medical Inc.
North America was the largest region in the vascular closure devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the vascular closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vascular closure devices market consists of sales of clip-based devices, suture-based devices, plug-based devices, and compression devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vascular Closure Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on vascular closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for vascular closure devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vascular closure devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Passive Approximators; Active Approximators; External Hemostatic Devices
2) By Access: Femoral Access; Radial Access
3) By End User: Acute Care Facilities; Hospitals; Clinics; Other End Users
Subsegments:
1) By Passive Approximators: Suture-Based Devices; Fibrin Sealants
2) By Active Approximators: Mechanical Devices; Expanding Devices
3) By External Hemostatic Devices: Compression Bandages; Adjustable Hemostatic Devices
Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic plc; Koninklijke Philips NV; Boston Scientific Corporation
3. Vascular Closure Devices Market Trends And Strategies
4. Vascular Closure Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Vascular Closure Devices Growth Analysis And Strategic Analysis Framework
5.1. Global Vascular Closure Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vascular Closure Devices Market Growth Rate Analysis
5.4. Global Vascular Closure Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vascular Closure Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vascular Closure Devices Total Addressable Market (TAM)
6. Vascular Closure Devices Market Segmentation
6.1. Global Vascular Closure Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Passive Approximators
Active Approximators
External Hemostatic Devices
6.2. Global Vascular Closure Devices Market, Segmentation By Access, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Femoral Access
Radial Access
6.3. Global Vascular Closure Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Care Facilities
Hospitals
Clinics
Other End Users
6.4. Global Vascular Closure Devices Market, Sub-Segmentation Of Passive Approximators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Suture-Based Devices
Fibrin Sealants
6.5. Global Vascular Closure Devices Market, Sub-Segmentation Of Active Approximators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mechanical Devices
Expanding Devices
6.6. Global Vascular Closure Devices Market, Sub-Segmentation Of External Hemostatic Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Compression Bandages
Adjustable Hemostatic Devices
7. Vascular Closure Devices Market Regional And Country Analysis
7.1. Global Vascular Closure Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vascular Closure Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
